Pfizer Inc.

NYSE:PFE   3:59:59 PM EDT
54.13
-0.82 (-1.49%)
4:54:03 PM EDT: $54.03 -0.10 (-0.19%)
Products, Strategic Combinations, Regulatory

Nikang Therapeutics And Pfizer Enter Clinical Trial Collaboration And Supply Agreement To Evaluate Novel Combination Therapies For The Treatment Of Advanced Clear Cell Renal Cell Carcinoma

Published: 11/30/2021 14:02 GMT
Pfizer Inc. (PFE) - Nikang Therapeutics and Pfizer Enter Clinical Trial Collaboration and Supply Agreement to Evaluate Novel Combination Therapies for the Treatment of Advanced Clear Cell Renal Cell Carcinoma.
Nikang - Will Sponsor Study, and Pfizer Will Co-fund Trials and Provide Its Drugs at No Cost to Nikang.
Nikang - Co, Pfizer Will Form a Joint Development Committee to Oversee This Collaboration.